Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation
Following allogeneic blood and marrow transplantation (BMT), graft-versus-host disease (GvHD) continues to represent a significant cause of treatment failure, despite the routine use of conventional, mainly calcineurin inhibitor-based prophylaxis. Recently, post-transplant cyclophosphamide (PTCy) ha...
| Հիմնական հեղինակներ: | , , , , , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | English |
| Հրապարակվել է: |
Frontiers Media S.A.
2020-04-01
|
| Շարք: | Frontiers in Immunology |
| Խորագրեր: | |
| Առցանց հասանելիություն: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00636/full |